BIOMAT Database Logo BIOMAT Database Logo

Placental protein 5 (PP5) in complicated pregnancies. 1981

A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn

Maternal serum PP5 concentrations were assayed in pregnancies complicated by intrauterine growth retardation, pre-eclampsia, diabetes mellitus, placental abruption and twins. Elevated PP5 levels were noted in twin pregnancies and to a lesser extent in diabetes and pre-eclampsia. Measurement of PP5 was of no value in the detection of fetal growth retardation. The great majority of PP5 levels above the normal range were associated with a placental abnormality.

UI MeSH Term Description Entries
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011254 Pregnancy in Diabetics The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy. Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D011272 Pregnancy, Multiple The condition of carrying two or more FETUSES simultaneously. Multiple Pregnancy,Multiple Pregnancies,Pregnancies, Multiple
D005260 Female Females
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Placental protein 5 (PP5) in placental abruption.
May 1981, British journal of obstetrics and gynaecology,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Placental protein 5 (PP5): biological and clinical studies.
January 1982, Placenta. Supplement,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
[Placental protein 5 (PP5), a new diagnostic dimension?].
June 1983, Medicina clinica,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Placental protein 5 (PP5)-like immunoreactivity in human urine.
January 1982, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Placental protein 5 (PP5) in severe pre-eclampsia and eclampsia.
March 1981, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Hyperstimulated human preovulatory follicular fluid contains placental protein 5 (PP5).
January 1984, Fertility and sterility,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen.
January 1985, Archives of gynecology,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Human endometrium and menstrual fluid contain placental protein 5 (PP5).
August 1986, Human reproduction (Oxford, England),
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
A method for the purification of placental protein 5 (PP5) from placental extracts.
July 1983, Clinica chimica acta; international journal of clinical chemistry,
A D Nisbet, and R D Bremner, and V Jandial, and H W Sutherland, and C W Horne, and H Bohn
Circulating levels of placental proteins, placental protein 5 (PP5), placental lactogen and Schwangerschafts-protein 1 (SP1), in antepartum eclampsia.
July 1983, British journal of obstetrics and gynaecology,
Copied contents to your clipboard!